Our Scientific Advisory Board

Philip Vickers, PhD

President and Chief Executive Officer at Solu Therapeutics

Dr. Phil Vickers is President and Chief Executive Officer at Solu Therapeutics.  With over 30 years of experience in the biopharma industry, Dr. Vickers brings a wealth of knowledge and experience to the Solu team.

His career includes R&D leadership roles of increasing responsibility at Merck Research Laboratories, Pfizer, Boehringer-Ingelheim and Shire Pharmaceuticals, where he was Global Head of R&D and a member of the Executive Leadership Team.  In addition to leading roles in major pharmaceutical companies, Dr. Vickers was also Chief Executive Officer at Northern Biologics and Faze Medicines.  His experiences span the development of both small molecules and biologics for common indications and rare diseases, and across multiple therapeutic areas – including oncology, immunology and inflammation, cardiovascular disease, and neurodegeneration. 

Dr. Vickers has a Ph.D. in Biochemistry from the University of Toronto, and prior to joining Merck he undertook postdoctoral studies at the National Cancer Institute in Bethesda, Maryland.


Philip Vickers, PhD Image